Cvs Health (CVS) Shareholder Independent Investors Raised Position by $764,400 as Market Valuation Declined; As Cyrusone (CONE) Market Value Declined, Chilton Capital Management Trimmed Its Position by $1.57 Million

CyrusOne Inc. (NASDAQ:CONE) Logo

Independent Investors Inc increased its stake in Cvs Health Corporation (CVS) by 99.29% based on its latest 2018Q3 regulatory filing with the SEC. Independent Investors Inc bought 9,800 shares as the company’s stock declined 3.04% with the market. The institutional investor held 19,670 shares of the medical and nursing services company at the end of 2018Q3, valued at $1.55M, up from 9,870 at the end of the previous reported quarter. Independent Investors Inc who had been investing in Cvs Health Corporation for a number of months, seems to be bullish on the $84.34B market cap company. The stock decreased 0.50% or $0.33 during the last trading session, reaching $65.22. About 16.74 million shares traded or 64.15% up from the average. CVS Health Corporation (NYSE:CVS) has risen 3.17% since February 3, 2018 and is uptrending. It has outperformed by 3.17% the S&P500. Some Historical CVS News: 13/04/2018 – CVS HEALTH NAMES MUNK ASSOCIATE CHIEF MEDICAL OFFICER; 06/03/2018 – MOODY’S RATES CVS’ PROPOSED SR UNSECURED NOTES Baa1; REMAINS ON; 13/04/2018 – CVS Health’s planned acquisition of health insurer Aetna was the largest corporate deal of 2017 at $69 billion; 22/03/2018 – CVS HEALTH GETS NCQA UTILIZATION MANAGEMENT ACCREDITATION; 13/04/2018 – CVS Hires Doctor From Health Startup in Sign of Medical Ambition; 06/03/2018 – CVS STILL MAY BE CUT BY MOODY’S ON DEBT FOR AETNA DEAL; 23/04/2018 – Glenview’s Robbins says talk of Amazon’s entering pharma is overblown; 16/04/2018 – CVS Health Appoints Kevin Hourican as President of CVS Pharmacy; 04/05/2018 – WSVN 7 News: #BREAKING: Jury decides to not press charges in 2017’s fatal CVS shooting in Davie; 11/05/2018 – CVS Health: Policy Solutions That Lower Drug Prices Are Aligned With CVS Business Model and Wouldn’t Be Expected to Hurt Profitability

Chilton Capital Management Llc decreased its stake in Cyrusone Inc (CONE) by 7.21% based on its latest 2018Q3 regulatory filing with the SEC. Chilton Capital Management Llc sold 24,995 shares as the company’s stock declined 14.44% with the market. The institutional investor held 321,752 shares of the real estate investment trusts company at the end of 2018Q3, valued at $20.40M, down from 346,747 at the end of the previous reported quarter. Chilton Capital Management Llc who had been investing in Cyrusone Inc for a number of months, seems to be less bullish one the $5.71B market cap company. The stock decreased 0.09% or $0.05 during the last trading session, reaching $54.15. About 880,897 shares traded. CyrusOne Inc. (NASDAQ:CONE) has declined 3.64% since February 3, 2018 and is downtrending. It has underperformed by 3.64% the S&P500. Some Historical CONE News: 18/04/2018 – Cramer also sits down with the CEOs of CyrusOne and Revance Therapeutics; 27/04/2018 – CYRUSONE – ON APRIL 20 & APRIL 26 CO, CYRUSONE DUTCH, ZTL SELLER REP ENTERED AMENDMENTS TO SALE & PURCHASE AGREEMENT, DATED DEC 21, 2017; 07/05/2018 – CyrusOne Takes Leading Role in Passage of Georgia Bill H.B. 696 Signed by Governor Nathan Deal; 29/03/2018 – CyrusOne Inc. Announces New $3.0 B Unsecured Credit Facility; 02/05/2018 – CYRUSONE SEES FY NORMALIZED FFO/SHR $3.18 TO $3.28, EST. $3.25; 29/03/2018 – CyrusOne Inc. Announces New $3.0 Billion Unsecured Credit Facility; 13/03/2018 – S&P Affirms ‘BB’ Corporate Credit Rating and ‘BB+’ Issue-Level Ratings on CyrusOne; 24/05/2018 – Cloud Provider Lume to Provide Retail Colocation from CyrusOne Data Centers; 19/04/2018 – DJ CyrusOne Inc, Inst Holders, 1Q 2018 (CONE); 13/03/2018 S&P REVISES CYRUSONE INC. OUTLOOK TO ‘POSITIVE’ FROM ‘STABLE’; RATING ‘BB’

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS inks new PBM contract with Walmart – Seeking Alpha” on January 18, 2019, also Bizjournals.com with their article: “Disney nominates CVS executive to board – L.A. Biz” published on January 11, 2019, Bizjournals.com published: “CVS eliminates 70 percent of retouched images in stores – Bizwomen – The Business Journals” on January 25, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “Why CVS Health Shares Dropped 18% in December – The Motley Fool” published on January 09, 2019 as well as Fool.com‘s news article titled: “Lightning Strikes the Least Popular Middlemen in Healthcare – Motley Fool” with publication date: February 02, 2019.

Among 28 analysts covering CVS Health (NYSE:CVS), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. CVS Health had 86 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Leerink Swann on Tuesday, April 10. Morgan Stanley maintained CVS Health Corporation (NYSE:CVS) on Tuesday, July 3 with “Overweight” rating. RBC Capital Markets maintained the shares of CVS in report on Wednesday, August 5 with “Outperform” rating. Citigroup maintained the shares of CVS in report on Thursday, August 17 with “Neutral” rating. The rating was maintained by S&P Research on Monday, November 2 with “Strong Buy”. Leerink Swann maintained the stock with “Outperform” rating in Friday, February 9 report. The rating was maintained by Argus Research with “Buy” on Monday, August 10. The firm has “Neutral” rating by Atlantic Securities given on Monday, February 6. Morgan Stanley upgraded the stock to “Overweight” rating in Friday, January 5 report. The rating was upgraded by Needham to “Buy” on Tuesday, January 30.

Independent Investors Inc, which manages about $239.99M and $283.68M US Long portfolio, decreased its stake in Philip Morris International (NYSE:PM) by 8,100 shares to 2,500 shares, valued at $203,000 in 2018Q3, according to the filing.

Investors sentiment increased to 1.12 in 2018 Q3. Its up 0.05, from 1.07 in 2018Q2. It increased, as 76 investors sold CVS shares while 459 reduced holdings. 144 funds opened positions while 456 raised stakes. 828.14 million shares or 1.36% more from 816.99 million shares in 2018Q2 were reported. Amundi Pioneer Asset Mngmt stated it has 0.28% of its portfolio in CVS Health Corporation (NYSE:CVS). Argyle Capital Mgmt Incorporated owns 42,510 shares for 1.25% of their portfolio. Mycio Wealth Prtnrs Limited Liability Corp, Pennsylvania-based fund reported 5,970 shares. Schroder Investment Group has invested 0.18% of its portfolio in CVS Health Corporation (NYSE:CVS). Oppenheimer holds 0.2% of its portfolio in CVS Health Corporation (NYSE:CVS) for 100,015 shares. Renaissance Invest Grp Inc Limited Company accumulated 2,587 shares. The Virginia-based Thompson Davis has invested 0.17% in CVS Health Corporation (NYSE:CVS). Regent Invest Mgmt Ltd Liability Co accumulated 1.64% or 66,323 shares. Randolph holds 279,395 shares. Franklin Resources Inc holds 0.46% or 11.74M shares. Renaissance Group Lc accumulated 28,460 shares. Nomura Asset Mgmt Ltd stated it has 388,331 shares or 0.3% of all its holdings. 4.30M were reported by Parametric Associates Limited. Spf Beheer Bv reported 1.10M shares. Cidel Asset holds 0.59% or 171,553 shares in its portfolio.

Since August 27, 2018, it had 0 insider buys, and 7 selling transactions for $18.41 million activity. $11.49 million worth of stock was sold by MERLO LARRY J on Tuesday, January 8. Brennan Troyen A had sold 14,229 shares worth $1.17 million on Wednesday, November 14. $1.03 million worth of CVS Health Corporation (NYSE:CVS) shares were sold by Boratto Eva C. Denton David M had sold 25,159 shares worth $2.02M. $642,300 worth of CVS Health Corporation (NYSE:CVS) shares were sold by Hourican Kevin.

Investors sentiment decreased to 1.55 in 2018 Q3. Its down 0.09, from 1.64 in 2018Q2. It worsened, as 23 investors sold CONE shares while 85 reduced holdings. 55 funds opened positions while 112 raised stakes. 102.88 million shares or 12.79% more from 91.21 million shares in 2018Q2 were reported. State Of Alaska Department Of Revenue holds 0.04% of its portfolio in CyrusOne Inc. (NASDAQ:CONE) for 41,940 shares. Ancora Lc holds 0.32% or 130,361 shares. First Dallas Securities Inc holds 0.18% of its portfolio in CyrusOne Inc. (NASDAQ:CONE) for 4,600 shares. Schwab Charles Management Inc reported 443,589 shares. D L Carlson Gp has invested 0.7% of its portfolio in CyrusOne Inc. (NASDAQ:CONE). Davis Selected Advisers owns 49,322 shares for 0.01% of their portfolio. Nordea Investment Mgmt Ab accumulated 280,902 shares or 0.04% of the stock. Bamco New York holds 271,922 shares or 0.07% of its portfolio. Oakbrook Invs Ltd has invested 0.02% in CyrusOne Inc. (NASDAQ:CONE). Partnervest Advisory Svcs Limited Co reported 27,317 shares. Gp Inc holds 201,460 shares. State Treasurer State Of Michigan holds 36,700 shares or 0.02% of its portfolio. Asset Mngmt holds 0.02% of its portfolio in CyrusOne Inc. (NASDAQ:CONE) for 5,157 shares. First Quadrant LP Ca holds 514 shares. 283,387 are owned by Retirement Of Alabama.

Chilton Capital Management Llc, which manages about $1.18B and $1.21 billion US Long portfolio, upped its stake in Visa Inc (NYSE:V) by 19,707 shares to 121,655 shares, valued at $18.26M in 2018Q3, according to the filing. It also increased its holding in Ishares Inc (IEMG) by 27,505 shares in the quarter, for a total of 92,062 shares, and has risen its stake in Anadarko Pete Corp (NYSE:APC).

More notable recent CyrusOne Inc. (NASDAQ:CONE) news were published by: Forbes.com which released: “5 REITs With Impressive Dividend Growth – Forbes” on January 14, 2019, also Bizjournals.com with their article: “Data center a first step in Goodyear’s quest for tech companies – Phoenix Business Journal” published on January 09, 2019, Nasdaq.com published: “CyrusOne Inc (CONE) Ex-Dividend Date Scheduled for December 31, 2018 – Nasdaq” on December 28, 2018. More interesting news about CyrusOne Inc. (NASDAQ:CONE) were released by: Businesswire.com and their article: “IBM Cloud Direct Link Now Available in CyrusOne Data Centers – Business Wire” published on February 01, 2019 as well as Nasdaq.com‘s news article titled: “First Week of September 20th Options Trading For CyrusOne (CONE) – Nasdaq” with publication date: February 01, 2019.

Since August 17, 2018, it had 0 insider purchases, and 2 insider sales for $1.16 million activity. Timmons Kevin L sold $495,222 worth of CyrusOne Inc. (NASDAQ:CONE) on Thursday, August 23.

CyrusOne Inc. (NASDAQ:CONE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.